In the present study, therefore, to assess the role of SLC20A1 expression in ER+ breast cancer subtypes in detail, we analyzed a METABRIC dataset that included the gene expression data from 1904 breast cancer patients. Here, SLC20A1 is linked to breast carcinoma.